Home Newsfeeds Apple Cuts iPhone 14 Plus Production Less Than Two Weeks After Debut

News

Apple Cuts iPhone 14 Plus Production Less Than Two Weeks After Debut

– Reuters Citing The Information

byBenzinga Newsdesk

October 18, 2022

1 minute read

– Reuters Citing The Information

Stephens & Co. Initiates Coverage On Cathay General with Equal-Weight Rating, Announces Price Target of $45

By Benzinga Newsdesk

July 14, 9:14 AM

Stephens & Co. analyst Andrew Terrell initiates coverage on Cathay General (NASDAQ:CATY) with a Equal-Weight rating and announces Price Target of $45.

CATY

Needham Reiterates Buy on Stoke Therapeutics, Maintains $25 Price Target

By Benzinga Newsdesk

March 7, 5:52 AM

Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $25 price target.

STOK

Global
News

Vaxcyte And Lonza Expand Collaboration For Global Commercial Manufacturing Of Broad-Spectrum Pneumococcal Conjugate Vaccines

By Benzinga Newsdesk

October 16, 8:32 AM

-- New Agreement to Establish Global Commercial Manufacturing Capacity for Vaxcyte's PCV Candidates, VAX-24 and VAX-31, in Adult and Pediatric Populations -- -- Expanded Collaboration Builds on Vaxcyte's Current

PCVX

Tesla Analyst Predicts Cybertruck’s Price Range, And It Seems To Be Cheaper Than Ford F-150 Lightning: ‘My Guess Is They Start With…’

By Shanthi Rexaline

September 7, 1:54 AM

The verdict is out, with most seeing Tesla's Cybertruck as a huge hit and having a halo effect on the company's rest of EV lineup.

Apple Cuts iPhone 14 Plus Production Less Than Two Weeks After Debut

Related Posts

Stephens & Co. Initiates Coverage On Cathay General with Equal-Weight Rating, Announces Price Target of $45

Needham Reiterates Buy on Stoke Therapeutics, Maintains $25 Price Target

Vaxcyte And Lonza Expand Collaboration For Global Commercial Manufacturing Of Broad-Spectrum Pneumococcal Conjugate Vaccines

Tesla Analyst Predicts Cybertruck’s Price Range, And It Seems To Be Cheaper Than Ford F-150 Lightning: ‘My Guess Is They Start With…’